Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Deutsches Arzteblatt International
|
October 26, 2011
Ovarian cancer: diagnosis and treatment
Alexander Burges, Barbara Schmalfeldt
Breast Cancer Research : BCR
|
July 3, 2010
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
Ansgar Brüning, Klaus Friese, Alexander Burges, et al.
Archives of Gynecology and Obstetrics
|
November 18, 2010
Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line
Alexander Burges, Naim Shabani, Ansgar Brüning, et al.
International Urogynecology Journal
|
January 16, 2015
Laparoscopic reconstruction of an iatrogenic perforation of the neovagina and urinary bladder by a neovaginal dilator in a patient with Mayer-Rokitansky-Küster-Hauser syndrome
Wael Y Khoder, Christian G Stief, Maximiliane Burgmann, et al.
Annals of the New York Academy of Sciences
|
October 8, 2008
DNA integrity in plasma and serum of patients with malignant and benign diseases
Stefan Holdenrieder, Alexander Burges, Oliver Reich, et al.
Investigational New Drugs
|
June 26, 2009
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Archives of Gynecology and Obstetrics
|
August 19, 2009
Squamous cell carcinoma arising in a dermoid cyst of the ovary in pregnancy
Helen Diana Budiman, Alexander Burges, Ina M Rühl, et al.
STAR Protocols
|
August 16, 2023
Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
Fabian Trillsch, Bastian Czogalla, Fabian Kraus, et al.
Gynecologic Oncology
|
April 3, 2007
Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)
Pauline Wimberger, Nils Lehmann, Rainer Kimmig, et al.
Cancers
|
May 14, 2022
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
Oliver Ingo Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Deutsches Arzteblatt International
|
October 26, 2011
Ovarian cancer: diagnosis and treatment
Alexander Burges, Barbara Schmalfeldt
Breast Cancer Research : BCR
|
July 3, 2010
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
Ansgar Brüning, Klaus Friese, Alexander Burges, et al.
Archives of Gynecology and Obstetrics
|
November 18, 2010
Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line
Alexander Burges, Naim Shabani, Ansgar Brüning, et al.
International Urogynecology Journal
|
January 16, 2015
Laparoscopic reconstruction of an iatrogenic perforation of the neovagina and urinary bladder by a neovaginal dilator in a patient with Mayer-Rokitansky-Küster-Hauser syndrome
Wael Y Khoder, Christian G Stief, Maximiliane Burgmann, et al.
Annals of the New York Academy of Sciences
|
October 8, 2008
DNA integrity in plasma and serum of patients with malignant and benign diseases
Stefan Holdenrieder, Alexander Burges, Oliver Reich, et al.
Investigational New Drugs
|
June 26, 2009
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib
Ansgar Brüning, Petra Burger, Marianne Vogel, et al.
Archives of Gynecology and Obstetrics
|
August 19, 2009
Squamous cell carcinoma arising in a dermoid cyst of the ovary in pregnancy
Helen Diana Budiman, Alexander Burges, Ina M Rühl, et al.
STAR Protocols
|
August 16, 2023
Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
Fabian Trillsch, Bastian Czogalla, Fabian Kraus, et al.
Gynecologic Oncology
|
April 3, 2007
Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)
Pauline Wimberger, Nils Lehmann, Rainer Kimmig, et al.
Cancers
|
May 14, 2022
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
Oliver Ingo Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Page
of 12